Responses
Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
645 Phase I study of adoptive T cell therapy following HER2-pulsed dendritic cell vaccine and pepinemab/trastuzumab in patients with metastatic HER2-positive breast cancer (MBC)
Compose a Response to This Article
Other responses
No responses have been published for this article.